Pediatrics Doctors in Sellersville, PA Accepting Medicare

20 Pediatrics doctors found. Showing 1 - 20

Hemalatha Guruprasad, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Lawn Ave, Chop Care Network At Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4476    Fax: 215-453-4738

Dr. Edward P Rothstein, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Julia B Harkness, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Lawn Ave, Chop Care Network At Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4476    Fax: 215-453-4738

Gopikrishna Gavini, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 Lawn Ave, Grand View Hospital - Chop Connection, Sellersville, PA 18960 Phone: 215-453-4082    Fax: 215-561-0959

Chaminie Wheeler, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 Lawn Ave, Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4082    Fax: 215-453-4738

Sheila M Knerr, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Lawn Ave, Chop Care Network At Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4476    Fax: 215-453-4738

Dr. Anna Sosnovsky, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 700 Lawn Ave, Sellersville, PA 18960 Phone: 215-453-5552

Anuta Dolha, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727

Deborah J Bolanowski, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Dr. Thomas I Kennedy, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Mohammad A Almomani, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 Lawn Ave, Grandview Hospital-chop Connection, Sellersville, PA 18960 Phone: 215-459-4082    Fax: 215-561-0959

Marion Mass, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 Lawn Ave, Chop Care Network At Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4476    Fax: 215-453-4738

Dr. Deborah R Faccenda, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Danielle Lee, Pediatrics Medicare: Medicare Enrolled Practice Location: 711 Lawn Avenue, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Christine P Newman, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Lawn Ave, Chop Care Network At Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4082    Fax: 215-453-4086

Dr. Erik F Lamberth, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Richard T Kratz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Michelle C Lindley, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Lawn Ave, Chop Care Network At Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4476    Fax: 215-453-4738

Dr. Ronald L Souder, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 711 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-2727    Fax: 215-257-8735

Andrew S Chu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Lawn Ave, Chop Care Network At Grandview Hospital, Sellersville, PA 18960 Phone: 215-453-4476    Fax: 215-453-4738

News Archive

Singularity University, BD establish collaborative relationship to tackle global healthcare challenges

Singularity University, a benefit corporation focused on empowering leaders to leverage exponentially growing technologies to tackle the world's greatest challenges, and BD (Becton, Dickinson and Company), a leading global medical technology company, have established a collaborative relationship where BD will leverage SU's expertise, innovation space, tools and inspiration to create new growth opportunities for healthcare and BD.

Genetic Immunity formulates first topically administered nanomedicine therapeutic vaccine for HIV/AIDS

Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.

Artificial womb could improve survival among premature babies

Researchers have designed a womb-like device that could allow premature babies to develop their lungs and organs in the critical few weeks that remain before they face the outside world.

Chemotherapy drugs also kill malaria parasite

A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.

Positive data on retreatment with brentuximab vedotin in Hodgkin lymphoma, ALCL presented at ASCO

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported data on Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL) patients retreated with single-agent brentuximab vedotin (SGN-35). Preliminary data demonstrate that objective responses were achieved in seven out of 11 retreatment experiences and that brentuximab vedotin was well-tolerated in the retreatment setting.

Read more Medical News

› Verified 6 days ago